- 1Laboratory of Stem Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
- 2Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
- 3Doctoral School of Exact and Natural Sciences, Jagiellonian University, Krakow, Poland
A Correction on
The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies
By Filipek-Gorzała J, Kwiecińska P, Szade A and Szade K (2024). Front. Oncol. 14:1308709. doi: 10.3389/fonc.2024.1308709
In the published article, there was a mistake in the Funding statement. The grant number for the Narodowe Centrum Nauki Harmonia Grant was displayed as “2020/01/Y/NZ3/00121”. The correct statement is “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The work is supported by Narodowe Centrum Nauki Harmonia Grant nr 2018/30/M/NZ5/00869 and European Research Council Starting Grant “StemMemo” nr 101041737 granted to KS and by the Strategic Programme Excellence Initiative at Jagiellonian University.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hematopoietic stem cell, preleukemic state, clonal hematopoiesis, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, mature cell neoplasm
Citation: Filipek-Gorzała J, Kwiecińska P, Szade A and Szade K (2025) Correction: The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies. Front. Oncol. 15:1633832. doi: 10.3389/fonc.2025.1633832
Received: 23 May 2025; Accepted: 26 May 2025;
Published: 24 June 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Filipek-Gorzała, Kwiecińska, Szade and Szade. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Krzysztof Szade, a3J6eXN6dG9mLnN6YWRlQHVqLmVkdS5wbA==